Genetic basis of multidrug resistance in acinetobacter clinical isolates in Taiwan

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 5, 2010, Pages 2078-2084

  Lin, Yu Chi ^a   Hsia, Ko Chiang ^a   Chen, Yee Chun ^b   Sheng, Wang Huei ^b   Chang, Shan Chwen ^b   Liao, Mei Hui ^a   Li, Shu Ying ^a  

^a CENTER FOR DISEASE CONTROL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CARBAPENEM; CEFEPIME; CEPHALOSPORIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; GENTAMICIN; IMIPENEM; LEUCINE; MEROPENEM; PIPERACILLIN; QUINOLONE DERIVATIVE; SERINE; TAZOBACTAM; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; INTEGRON; MICROBIAL GENETICS; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SUBSPECIES; TAIWAN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AMINOGLYCOSIDES; BETA-LACTAMASES; CARBAPENEMS; CEPHALOSPORINS; DNA GYRASE; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE; FLUOROQUINOLONES; HUMANS; TAIWAN;

EID: 77951220186     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01398-09     Document Type: Article

References (41)

1. Bergogne-Bérézin, E., and K. J. Towner. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9:148-165.
2. Bou, G., and J. Martinez-Beltran. 2000. Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC beta-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 44:428-432.
3. Bratu, S., D. Landman, D. A. Martin, C. Georgescu, and J. Quale. 2008. Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City. Antimicrob. Agents Chemother. 52:2999-3005.
4. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing: fifteenth informational supplement, M100-S15. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Corvec, S., N. Caroff, E. Espaze, C. Giraudeau, H. Drugeon, and A. Reynaud. 2003. AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains. J. Antimicrob. Chemother. 52:629-635.
6. Danes, C., M. M. Navia, J. Ruiz, F. Marco, A. Jurado, M. T. Jimenez de Anta, and J. Vila. 2002. Distribution of beta-lactamases in Acinetobacter baumannii clinical isolates and the effect of Syn 2190 (AmpC inhibitor) on the MICs of different beta-lactam antibiotics. J. Antimicrob. Chemother. 50:261-264.
7. Dijkshoorn, L., A. Nemec, and H. Seifert. 2007. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5:939-951.
8. Figueiredo, S., L. Poirel, J. Croize, C. Recule, and P. Nordmann. 2009. In vivo selection of reduced susceptibility to carbapenems in Acinetobacter baumannii related to ISAba1-mediated overexpression of the natural bla(OXA-66) oxacillinase gene. Antimicrob. Agents Chemother. 53:2657-2659.
9. Héritier, C., L. Poirel, P. E. Fournier, J. M. Claverie, D. Raoult, and P. Nordmann. 2005. Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob. Agents Chemother. 49:4174-4179.
10. Héritier, C., L. Poirel, T. Lambert, and P. Nordmann. 2005. Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother. 49:3198-3202.
11. Héritier, C., L. Poirel, and P. Nordmann. 2006. Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii. Clin. Microbiol. Infect. 12:123-130.
12. Hu, W. S., S. M. Yao, C. P. Fung, Y. P. Hsieh, C. P. Liu, and J. F. Lin. 2007. An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii. Antimicrob. Agents Chemother. 51:3844-3852.
13. Huang, L. Y., T. L. Chen, P. L. Lu, C. A. Tsai, W. L. Cho, F. Y. Chang, C. P. Fung, and L. K. Siu. 2008. Dissemination of multidrug-resistant, class 1 integron-carrying Acinetobacter baumannii isolates in Taiwan. Clin. Microbiol. Infect. 14:1010-1019.
14. Hujer, K. M., N. S. Hamza, A. M. Hujer, F. Perez, M. S. Helfand, C. R. Bethel, J. M. Thomson, V. E. Anderson, M. Barlow, L. B. Rice, F. C. Tenover, and R. A. Bonomo. 2005. Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymes. Antimicrob. Agents Chemother. 49:2941-2948.
15. Hunger, M., R. Schmucker, V. Kishan, and W. Hillen. 1990. Analysis and nucleotide sequence of an origin of DNA replication in Acinetobacter calcoaceticus and its use for Escherichia coli shuttle plasmids. Gene 87:45-51.
16. Lee, J. H., C. H. Choi, H. Y. Kang, J. Y. Lee, J. Kim, Y. C. Lee, S. Y. Seol, D. T. Cho, K. W. Kim, D. Y. Song, and J. C. Lee. 2007. Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species 13TU. J. Antimicrob. Chemother. 59:633-639.
17. Lee, Y. T., L. Y. Huang, D. H. Chiang, C. P. Chen, T. L. Chen, F. D. Wang, C. P. Fung, L. K. Siu, and W. L. Cho. 2009. Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan. Int. J. Antimicrob. Agents 34:580-584.
18. Lévesque, C., L. Piche, C. Larose, and P. H. Roy. 1995. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents Chemother. 39:185-191.
19. Lim, Y. M., K. S. Shin, and J. Kim. 2007. Distinct antimicrobial resistance patterns and antimicrobial resistance-harboring genes according to genomic species of Acinetobacter isolates. J. Clin. Microbiol. 45:902-905.
20. Lin, Y. C., W. H. Sheng, S. C. Chang, J. T. Wang, Y. C. Chen, R. J. Wu, K. C. Hsia, and S. Y. Li. 2008. Application of a microsphere-based array for rapid identification of Acinetobacter spp. with distinct antimicrobial susceptibilities. J. Clin. Microbiol. 46:612-617.
21. Livermore, D. M., and N. Woodford. 2000. Carbapenemases: a problem in waiting? Curr. Opin. Microbiol. 3:489-495.
22. Lockhart, S. R., M. A. Abramson, S. E. Beekmann, G. Gallagher, S. Riedel, D. J. Diekema, J. P. Quinn, and G. V. Doern. 2007. Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. J. Clin. Microbiol. 45:3352-3359.
23. Lu, P. L., M. Doumith, D. M. Livermore, T. P. Chen, and N. Woodford. 2009. Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase. J. Antimicrob. Chemother. 63:641-647.
24. Mazel, D. 2006. Integrons: agents of bacterial evolution. Nat. Rev. Microbiol. 4:608-620.
25. Mendes, R. E., J. M. Bell, J. D. Turnidge, M. Castanheira, and R. N. Jones. 2009. Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program. J. Antimicrob. Chemother. 63:55-59.
26. Mugnier, P. D., L. Poirel, and P. Nordmann. 2009. Functional analysis of insertion sequence ISAba1 responsible for genomic plasticity of Acinetobacter baumannii. J. Bacteriol. 191:2414-2418.
27. Munoz-Price, L. S., and R. A. Weinstein. 2008. Acinetobacter infection. N. Engl. J. Med. 358:1271-1281.
28. Peleg, A. Y., H. Seifert, and D. L. Paterson. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21:538-582.
29. Pitout, J. D., D. B. Gregson, L. Poirel, J. A. McClure, P. Le, and D. L. Church. 2005. Detection of Pseudomonas aeruginosa producing metallobeta- lactamases in a large centralized laboratory. J. Clin. Microbiol. 43:3129-3135.
30. Poirel, L., and P. Nordmann. 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12:826-836.
31. Poirel, L., and P. Nordmann. 2006. Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-58 in Acinetobacter baumannii. Antimicrob. Agents Chemother. 50:1442-1448.
32. Qi, C., M. Malczynski, M. Parker, and M. H. Scheetz. 2008. Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007. J. Clin. Microbiol. 46:1106-1109.
33. Queenan, A. M., and K. Bush. 2007. Carbapenemases: the versatile betalactamases. Clin. Microbiol. Rev. 20:440-458.
34. Rather, P. N., H. Munayyer, P. A. Mann, R. S. Hare, G. H. Miller, and K. J. Shaw. 1992. Genetic analysis of bacterial acetyltransferases: identification of amino acids determining the specificities of the aminoglycoside 6′-N-acetyltransferase Ib and IIa proteins. J. Bacteriol. 174:3196-3203.
35. Segal, H., E. C. Nelson, and B. G. Elisha. 2004. Genetic environment and transcription of ampC in an Acinetobacter baumannii clinical isolate. Antimicrob. Agents Chemother. 48:612-614.
36. Sheng, W. H., Y. C. Lin, J. T. Wang, Y. C. Chen, S. C. Chang, K. C. Hsia, R. J. Wu, and S. Y. Li. 2009. Identification of distinct ciprofloxacin susceptibility in Acinetobacter spp. by detection of the gyrA gene mutation using real-time PCR. Mol. Cell. Probes 23:154-156.
37. Touati, A., L. Brasme, S. Benallaoua, A. Gharout, J. Madoux, and C. De Champs. 2008. First report of qnrB-producing Enterobacter cloacae and qnrA-producing Acinetobacter baumannii recovered from Algerian hospitals. Diagn. Microbiol. Infect. Dis. 60:287-290.
38. Turton, J. F., M. E. Kaufmann, J. Glover, J. M. Coelho, M. Warner, R. Pike, and T. L. Pitt. 2005. Detection and typing of integrons in epidemic strains of Acinetobacter baumannii found in the United Kingdom. J. Clin. Microbiol. 43:3074-3082.
39. Turton, J. F., M. E. Ward, N. Woodford, M. E. Kaufmann, R. Pike, D. M. Livermore, and T. L. Pitt. 2006. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol. Lett. 258:72-77.
40. Vila, J., J. Ruiz, P. Goni, A. Marcos, and T. Jimenez de Anta. 1995. Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 39:1201-1203.
41. Woodford, N., M. J. Ellington, J. M. Coelho, J. F. Turton, M. E. Ward, S. Brown, S. G. Amyes, and D. M. Livermore. 2006. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 27:351-353.